Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Rolland

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Fundamental & Clinical Pharmacology|March 28, 2021
Doctor shopping for methylphenidate as a proxy for misuse and potential abuse in the 67 million inhabitants in FranceBenjamin Rolland
Schizophrenia Research|December 3, 2014
Cortico-accumbens circuitry in schizophrenia: merely a "reward system"?Benjamin Rolland, Renaud Jardri
Current Pharmaceutical Design|August 5, 2015
Editorial: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the MazeBenjamin Rolland, Ali Amad
Current Drug Targets|April 20, 2013
The first theme issue on PPARs for brain disordersBenjamin Rolland, Régis Bordet
CNS Drugs|February 17, 2017
Binge Drinking: Current Diagnostic and Therapeutic IssuesBenjamin Rolland, Mickaël Naassila
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2022
Reply to "Alcohol-related liver disease treatment and EBM"Alexandre Louvet, Benjamin Rolland,
Frontiers in Psychiatry|October 31, 2022
Baclofen in alcohol use disorder: An analysis of the data provided by the French "Temporary Recommendation for Use" 2014-2017 cohortRenaud de Beaurepaire, Benjamin Rolland
Journal of Substance Abuse Treatment|July 25, 2015
Interventions for Increasing Alcohol Treatment Utilization Among Patients with Alcohol Use Disorders from Emergency Departments: A Systematic ReviewNicolas Simioni, Benjamin Rolland, Olivier Cottencin
Current Pharmaceutical Design|September 5, 2013
New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literatureOlivier Cottencin, Benjamin Rolland, Laurent Karila
Addiction (Abingdon, England)|October 15, 2015
Is there really no evidence of the efficacy of brief alcohol interventions for increasing subsequent utilization of alcohol-related services? Commentary on the paper by Glass et al. (2015)Nicolas Simioni, Benjamin Rolland, Olivier Cottencin
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Fundamental & Clinical Pharmacology|March 28, 2021
Doctor shopping for methylphenidate as a proxy for misuse and potential abuse in the 67 million inhabitants in FranceBenjamin Rolland
Schizophrenia Research|December 3, 2014
Cortico-accumbens circuitry in schizophrenia: merely a "reward system"?Benjamin Rolland, Renaud Jardri
Current Pharmaceutical Design|August 5, 2015
Editorial: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the MazeBenjamin Rolland, Ali Amad
Current Drug Targets|April 20, 2013
The first theme issue on PPARs for brain disordersBenjamin Rolland, Régis Bordet
CNS Drugs|February 17, 2017
Binge Drinking: Current Diagnostic and Therapeutic IssuesBenjamin Rolland, Mickaël Naassila
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2022
Reply to "Alcohol-related liver disease treatment and EBM"Alexandre Louvet, Benjamin Rolland,
Frontiers in Psychiatry|October 31, 2022
Baclofen in alcohol use disorder: An analysis of the data provided by the French "Temporary Recommendation for Use" 2014-2017 cohortRenaud de Beaurepaire, Benjamin Rolland
Journal of Substance Abuse Treatment|July 25, 2015
Interventions for Increasing Alcohol Treatment Utilization Among Patients with Alcohol Use Disorders from Emergency Departments: A Systematic ReviewNicolas Simioni, Benjamin Rolland, Olivier Cottencin
Current Pharmaceutical Design|September 5, 2013
New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literatureOlivier Cottencin, Benjamin Rolland, Laurent Karila
Addiction (Abingdon, England)|October 15, 2015
Is there really no evidence of the efficacy of brief alcohol interventions for increasing subsequent utilization of alcohol-related services? Commentary on the paper by Glass et al. (2015)Nicolas Simioni, Benjamin Rolland, Olivier Cottencin
Pageof 23